Skip to main content

Table 1 Schedule of enrollment, interventions and assessments during this study according to SPIRIT [28]

From: Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial

Study period

 

Enrollment/allocation

Post-allocation

Follow-up

 

Close-out

Timepoint

D0 (= BL)

D0 (= BL)

W1, W2, W3

W4

W12

Enrollment

     

 Clinical evaluation

X

    

 Eligibility screen

X

    

 Allocation

X

    

Interventions

     

 rESWT

 

X

X

  

 C + E

 

X

X

  

Assessments

     

 A, G, BH, BW, Du, ES, MS, Co

X

    

 Safety

 

X

X

X

X

 PSEQ score

X

 

X

X

X

 NRS score

X

 

X

X

X

 OLBPDQ score

X

 

X

X

X

 PHQ-9 score

X

 

X

X

X

  1. D0, day zero; BL, baseline; W, week; rESWT, radial extracorporeal shock wave therapy; C + E, celecoxib and eperisone; A, age; G, gender; BH, body height; BW, body weight; Du, duration, ES, education status; MS, marriage status; Co, comorbidities; PSEQ, Pain Self-Efficacy Questionnaire; NRS, numerical rating scale; OLDPDQ, Oswestry Low Back Pain Disability Questionnaire; PHQ-9, Patient Health Questionnaire 9
Back to article page

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X